1887
Preview this article:
Zoom in
Zoomout

Improving turnaround time for identifying extended-spectrum β-lactamase-producing and : experience with the BD Phoenix automated system, Page 1 of 1

| /docserver/preview/fulltext/jmm/60/5/679_jmm022285-1.gif

There is no abstract available for this article.
Use the preview function to the left.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.022285-0
2011-05-01
2019-10-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/60/5/679.html?itemId=/content/journal/jmm/10.1099/jmm.0.022285-0&mimeType=html&fmt=ahah

References

  1. CLSI (2008). Performance Standards for Antimicrobial Susceptibility Testing; 18th Informational Supplement. M100-S18. Wayne, PA: Clinical and Laboratory Standards Institute.
  2. CLSI (2010). Performance Standards for Antimicrobial Susceptibility Testing; 20th Informational Supplement. M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute.
  3. Drieux L., Brossier F., Sougakoff W., Jarlier V.. ( 2008;). Phenotypic detection of extended-spectrum β-lactamase production in Enterobacteriaceae: review and bench guide. . Clin Microbiol Infect 14: Suppl. 190–103. [CrossRef][PubMed]
    [Google Scholar]
  4. Färber J., Moder K. A., Layer F., Tammer I., König W., König B.. ( 2008;). Extended-spectrum β-lactamase detection with different panels for automated susceptibility testing and with a chromogenic medium. . J Clin Microbiol 46:, 3721–3727. [CrossRef][PubMed]
    [Google Scholar]
  5. Fisher M. A., Stamper P. D., Hujer K. M., Love Z., Croft A., Cohen S., Bonomo R. A., Carroll K. C., Petti C. A.. ( 2009;). Performance of the Phoenix bacterial identification system compared with disc diffusion methods for identifying extended-spectrum β-lactamase, AmpC and KPC producers. . J Med Microbiol 58:, 774–778. [CrossRef][PubMed]
    [Google Scholar]
  6. Pitout J. D. D., Laupland K. B.. ( 2008;). Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. . Lancet Infect Dis 8:, 159–166. [CrossRef][PubMed]
    [Google Scholar]
  7. Rodríguez-Baño J., Pascual A.. ( 2008;). Clinical significance of extended-spectrum β-lactamases. . Expert Rev Anti Infect Ther 6:, 671–683. [CrossRef][PubMed]
    [Google Scholar]
  8. Rodriguez-Villalobos H., Malaviolle V., Frankard J., de Mendonça R., Nonhoff C., Struelens M. J.. ( 2006;). In vitro activity of temocillin against extended spectrum β-lactamase-producing Escherichia coli. . J Antimicrob Chemother 57:, 771–774. [CrossRef][PubMed]
    [Google Scholar]
  9. Wiegand I., Geiss H. K., Mack D., Stürenburg E., Seifert H.. ( 2007;). Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures. . J Clin Microbiol 45:, 1167–1174. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.022285-0
Loading
/content/journal/jmm/10.1099/jmm.0.022285-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error